Search results for "Minas"

showing 10 items of 287 documents

The production of the oral mucosa of antiendomysial and anti-tissue-transglutaminase antibodies in patients with celiac disease: a review.

2010

Celiac disease (CD) is a lifelong, T cell—mediated enteropathy, triggered by the ingestion of gluten and related prolamins in genetically susceptible subjects, resulting in minor intestinal mucosal injury, including villous atrophy with crypt hyperplasia and intraepithelial lymphocytosis, and subsequent nutrient malabsorption. Although serological tests for antiendomysial (EMA) and anti—tissue transglutaminase (anti-tTG) autoantibodies are used to screen and follow up on patients with CD, diagnostic confirmation is still based on the histological examination of the small intestinal mucosa. Although the small intestinal mucosa is the main site of the gut involved in CD, other mucosal surface…

medicine.medical_specialtySettore MED/09 - Medicina InternaMalabsorptionGlutensTissue transglutaminaseBiopsyantiendomysial antibodieslcsh:Medicineoral biopsyReview Articlelcsh:TechnologyGastroenterologySensitivity and SpecificityGeneral Biochemistry Genetics and Molecular BiologySettore MED/28 - Malattie Odontostomatologicheanti–tissue transglutaminase antibodiesInternal medicineBiopsymedicineHumansEnteropathyOral mucosalcsh:ScienceGeneral Environmental ScienceAutoantibodiesSettore MED/12 - GastroenterologiaGastrointestinal tractTransglutaminasesbiologymedicine.diagnostic_testoral mucosalcsh:Tbusiness.industrylcsh:RMouth MucosaMuscle SmoothGeneral Medicinemedicine.diseaseCeliac Diseasemedicine.anatomical_structureceliac disease oral mucosa anti–tissue transglutaminase antibodies antiendomysial antibodies oral biopsy.Immunologybiology.proteinIntraepithelial lymphocytelcsh:QGliadinbusinessTheScientificWorldJournal
researchProduct

Estudio de seguimiento de los niveles de vitamina d en pacientes con lupus eritematoso cutáneo y correlación con la severidad de la enfermedad

2014

INTRODUCCIÓN: La fuente más importante de vitamina D es la exposición de la piel a la radiación ultravioleta. Se han encontrado niveles bajos de vitamina D en pacientes con enfermedades autoinmunes, incluyendo diabetes tipo I, artritis reumatoide, esclerosis múltiple y lupus eritematoso sistémico. El lupus eritematoso cutáneo (LEC) se exacerba por la exposición solar y no existen estudios sobre prevalencia del déficit de vitamina D en los pacientes con LEC. Asimismo, se ha encontrado relación entre los niveles bajos de vitamina D y la prevalencia de enfermedades cardiovasculares. Esta asociación podría deberse a una relación entre los niveles de vitamina D y de lípidos en sangre. Llevamos a…

ciencias médicas:CIENCIAS MÉDICAS ::Ciencias clínicas::Dermatología [UNESCO]:CIENCIAS MÉDICAS ::Medicina interna::Reumatología [UNESCO]fungiUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Dermatologíahormonas:CIENCIAS MÉDICAS ::Medicina interna::Endocrinología [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Medicina interna::EndocrinologíaUNESCO::CIENCIAS MÉDICAS ::Medicina interna::Reumatologíavitaminasepidemiología
researchProduct

Enzymatic and pharmacokinetic studies on the metabolism of branched chain alpha-keto acids in the rat.

1983

Michaelis-constants and enzyme activities for dehydrogenation and transamination of the three branched chain alpha-keto acids in liver, kidney, skeletal muscle, and brain of rats are reported. After oral load only 11-22% of the keto acids pass the liver unchanged. Blood levels in pharmacokinetic and absorption studies are related to the Michaelis-constants. At the low keto-acid concentrations after oral application, dehydrogenation in the non-hepatic tissues is supposed to prevail over transamination. Data on feed efficiency of branched chain alpha-keto acids reported in the literature support this view. The chance for transamination is better after intravenous administration. The transfera…

MaleStereochemistryTransaminationMedicine (miscellaneous)Mitochondria LiverKidneyBiochemistryHemiterpenesPharmacokineticsmedicineAnimalsDehydrogenationTransaminases3-methyl-2-oxobutyratechemistry.chemical_classificationKidneyCell-Free SystemSkeletal muscleBrainRats Inbred StrainsMetabolismKeto AcidsMitochondriaMitochondria MuscleRatsKineticsmedicine.anatomical_structureEnzymeBiochemistrychemistryOxidoreductasesFood ScienceZeitschrift fur Ernahrungswissenschaft
researchProduct

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

2013

Treatment with peginterferon α-2a (PegIFN) for 48 weeks is the standard of care for selected HBeAg-negative patients chronically infected with hepatitis B virus (HBV), but with limited treatment efficacy. A study was undertaken to investigate whether treatment extension to 96 weeks improves the outcome in this patient population.128 HBeAg-negative patients (120 genotype D) were randomised to weekly 180 μg PegIFN for 48 weeks (group A, n=51), 180 μg PegIFN for 48 weeks followed by 135 μg weekly for an additional 48 weeks (group B, n=52) or 180 μg PegIFN plus lamivudine (100 mg/day) for 48 weeks then 135 μg PegIFN for 48 weeks (group C, n=25). Endpoints were alanine aminotransferase normalisa…

AdultMaleHBsAgmedicine.medical_specialtyHepatitis B virusTime FactorsAnti-HIV Agentsmedicine.disease_causeGastroenterologyAntiviral AgentsGroup Blaw.inventionPolyethylene GlycolsPharmacotherapyHepatitis B ChronicRandomized controlled triallawPegylated interferonInternal medicinemedicineHumansHepatitis B e AntigensHepatitis B virusbusiness.industryGastroenterologyLamivudineInterferon-alphaAlanine TransaminaseHepatitis BMiddle Agedmedicine.diseaseHepatitis BRecombinant ProteinsTreatment OutcomeLamivudineImmunologyDNA ViralInterferonDrug Therapy CombinationFemaleHepatitis B; Interferonbusinessmedicine.drug
researchProduct

Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta.

2001

Although many patients with chronic viral hepatitis C infection suffer from progressive liver disease, the rate of fibrosis progression is highly variable and some patients do not show any measurable progression. However, our ability to predict which patients progress is very limited. Since transforming growth factor-beta (TGF-beta) is a key mediator of liver fibrogenesis, we assessed the predictive role of TGF-beta for fibrogenesis in chronic hepatitis C. We studied 39 patients with chronic hepatitis C in whom two liver biopsies were taken at least 12 months apart, and who did not receive therapy during this period. TGF-beta was measured by bioassay and by ELISA in serum samples taken at t…

Liver CirrhosisMalePathologymedicine.medical_specialtyCirrhosisAntiviral AgentsSeverity of Illness IndexFibrosisPredictive Value of TestsTransforming Growth Factor betaVirologyBiopsymedicineHumansHepatologymedicine.diagnostic_testbusiness.industryAlanine TransaminaseHepatitis CHepatitis C ChronicMiddle AgedViral Loadmedicine.diseaseInfectious DiseasesLiver biopsyPredictive value of testsChronic DiseaseDisease ProgressionFemalebusinessViral loadProgressive diseaseBiomarkersProcollagenJournal of viral hepatitis
researchProduct

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

1999

Fluctuations of hepatitis C virus (HCV)-RNA serum levels were monitored in a multicenter study in 76 chronic HCV carriers who had been followed longitudinally without receiving antiviral therapy to assess their relation with the course of liver disease activity. Forty-four patients had normal transaminases over more than 2 years, while 32 additional patients had fluctuating levels. Viral load was measured in serial serum samples prospectively collected for 10 to 12 months in 54 patients and in sera stored yearly up to 8 years in an additional 22 patients. In patients tested monthly, a lesser extent of fluctuations was detected in cases with constantly normal transaminases as compared with t…

AdultMalemedicine.medical_specialtyGenotypeHepatitis C virusHepacivirusViremiaHepacivirusmedicine.disease_causeGastroenterologyAsymptomaticLiver diseaseFlaviviridaeInternal medicinemedicineHumansLongitudinal StudiesViremiaAgedHepatologybiologybusiness.industryAlanine TransaminaseHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationLiverImmunologyCarrier StateRNA ViralFemaleViral diseasemedicine.symptombusinessViral loadHepatology (Baltimore, Md.)
researchProduct

The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: …

2008

Introduction The treatment of septic conditions in critically ill patients is still one of medicine's major challenges. Cyclic nucleotides, adenosine and its receptors play a pivotal role in the regulation of inflammatory responses and in limiting inflammatory tissue destruction. The aim of this study was to verify the hypothesis that adenosine deaminase-1 and cyclic guanosine monophosphate-stimulated phosphodiesterase inhibition by erythro-9-[2-hydroxyl-3-nonyl]-adenine could be beneficial in experimental endotoxicosis/sepsis. Method We used two established animal models for endotoxicosis and sepsis. Twenty-four male Wistar rats that had been given intravenous endotoxin (Escherichia coli l…

LipopolysaccharidesMaleLipopolysaccharideAdenosine DeaminasePharmacologyCritical Care and Intensive Care MedicinePermeabilitySepsisExcretionMicechemistry.chemical_compoundSepsisAdenosine Deaminase InhibitorsmedicineAnimalsProspective StudiesRats WistarPhosphodiesterase inhibitorIntestinal permeabilitybusiness.industrySeptic shockAdenineResearchmedicine.diseaseAdenosineRatsIntestinal AbsorptionchemistryImmunologyFemaleAdenosine Deaminase Inhibitorbusinessmedicine.drugCritical Care
researchProduct

Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis.

2008

In post-infancy, multinucleated giant cell hepatitis is rare. Various conditions and diseases associated with post-infantile giant cell hepatitis have been described, but the pathogenesis remains unknown. In this paper we review the case reports of four patients (3 male, 1 female; aged 22 to 32 years) with primary sclerosing cholangitis and autoimmune hepatitis. The follow-up ranges from five to seven years. All patients showed cholestasis and repeated elevation of hepatic transaminases. Patients with viral infections, metabolic disorders and toxic influences were excluded. Histopathology of liver tissue in all four patients revealed giant cell formation with up to 20 nuclei in 20-70% of al…

AdultMalemedicine.medical_specialtyPathologyCirrhosisCholangitisAutoimmunityAutoimmune hepatitisGiant CellsPrimary sclerosing cholangitisHepatitisCholestasisAdrenal Cortex HormonesHLA AntigensmedicineHumansAspartate AminotransferasesAutoimmune diseaseHepatitisCholangiopancreatography Endoscopic RetrogradeCholestasisHepatologybusiness.industryHistocytochemistryUrsodeoxycholic AcidAlanine TransaminaseBilirubinmedicine.diseaseSerologyGiant cellHistopathologyFemalebusinessImmunosuppressive AgentsLiver
researchProduct

Addressing substrate glutamine requirements for tissue transglutaminase using substance P analogues

1999

AbstractWe have investigated the effect on the substrate requirements for guinea pig liver (tissue) transglutaminase of a set of 11 synthetic glutamine substitution analogues making up the full sequence of the naturally occurring tissue transglutaminase substrate substance P. While a number of peptide sequences derived from proteins that are well-recognized as tissue transglutaminase substrates have been studied, the enzyme activity using substitution analogues of full-length natural substrates has not been investigated as thoroughly. Thus, our set of substance P analogues only differs from one to other by one amino acid mutation while the length (of the peptide) is maintained as in the nat…

Tissue transglutaminaseStereochemistryGlutamineGuinea PigsMolecular Sequence DataBiophysicsPeptideSubstance PBiochemistrySubstance P analogueSubstrate SpecificityResidue (chemistry)Structural BiologyGeneticsAnimalsAmino Acid SequenceMolecular Biologychemistry.chemical_classificationTransglutaminasesbiologySubstrate (chemistry)Cell BiologyTransglutaminasePeptide FragmentsEnzyme assayMultiple peptide synthesisAmino acidGlutamineEnzymeLiverchemistryBiochemistryMutationbiology.proteinFEBS Letters
researchProduct

A surgical model for isolating the pig liver in vivo for gene therapy.

2013

Several studies report results that suggest the need of vascularization blocking for efficient gene transfer to the liver, especially in nonviral gene therapy. In this study, we describe a surgical strategy for in vivo isolation of the pig liver, resulting in a vascular watertight organ that allows the evaluation of several gene injection conditions. The hepatic artery and portal, suprahepatic and infrahepatic cava veins were dissected. Then, liver vascularization was excluded for 5-7 min. In that time, we first injected 200 ml saline solution containing the p3c-eGFP plasmid (20 µg/ml) simultaneously through two different catheters placed in the portal and cava veins, respectively. Vital co…

Models AnatomicPathologymedicine.medical_specialtySwinemedicine.medical_treatmentGenetic enhancementPremedicationGreen Fluorescent ProteinsGene deliveryAndrologyIn vivomedicineAnimalsAspartate AminotransferasesSalineGenebusiness.industryHemodynamicsRNAAlanine TransaminaseGenetic Therapymedicine.anatomical_structureLiverSurgeryFemalebusinessPerfusionArtery
researchProduct